"Obstetrics and Gynecology is healthcare designed for women’s special needs. Our services focus on you, from the confirmation of pregnancy to the sound of your infant’s cry. We conduct lab tests to assure you of the safety of both you and your baby, perform ultrasounds to see your infant’s first movements, provide nursing personnel to answer any concerns, and have an excellent team of physicians readily available to give you confidence and assistance when needed. Our practice is dedicated to caring for a woman’s unique needs in a manner and quality that she deserves. We can advise you about contraception, perform routine yearly check-ups, and help restore normal levels of health when problems occur."

During the past decade, NEA Women's Clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NEA Women's Clinic" #1 sponsor was "Lumara Health, Inc." with 2 trials, followed by "Ferring Pharmaceuticals" with 1 trials sponsored, "Graceway Pharmaceuticals, LLC" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Noven Therapeutics" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "NEA Women's Clinic" are "Genital Herpes" (1 trials), "Hot Flashes" (1 trials), "Infertility" (1 trials), "Overactive Bladder" (1 trials) and "Postmenopausal Symptoms" (1 trials). Many other conditions were trialed in "NEA Women's Clinic" in a lesser frequency.

Most popular intervention types in "NEA Women's Clinic" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Brisdelle (paroxetine mesylate)" (1 trials), "Estradiol transdermal one 90 μL spray" (1 trials), "Estradiol transdermal spray, two 90 μL sprays" (1 trials), "Estradiol transdermal three 90 μL sprays" (1 trials) and "Famciclovir" (1 trials). Other intervention names were less common.

The vast majority of trials in "NEA Women's Clinic" are 5 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "NEA Women's Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in NEA Women's Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NEA Women's Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".